Intravitreal dexamethasone implant for acute exudative polymorphous vitelliform maculopathy

Andrea Scupola, Edoardo Abed, Maria Grazia Sammarco, Salvatore Traina, Antonio Villano, Gabriela Grimaldi, Maria Antonietta Blasi

Risultato della ricerca: Contributo in rivistaArticolo in rivista

5 Citazioni (Scopus)


Acute exudative polymorphous vitelliform maculopathy is a rare retinal disease characterized by bilateral serous macular detachment and subretinal accumulation of yellowish deposits resembling Best dystrophy lesions. Corticosteroid systemic therapy has been used empirically in the attempt to treat this retinal disorder with mixed results. Thus, the benefit of corticosteroid remains undetermined. To our knowledge, we report the first case of acute exudative polymorphous vitelliform maculopathy (AEPVM) treated in one eye with intravitreal dexamethasone implant (Ozurdex; Allergan, Inc., Irvine, California, USA).
Lingua originaleEnglish
pagine (da-a)803-807
Numero di pagine5
RivistaEuropean Journal of Ophthalmology
Stato di pubblicazionePubblicato - 2014


  • Acute Disease
  • Adult
  • Coloring Agents
  • Dexamethasone
  • Drug Implants
  • Exudates and Transudates
  • Fluorescein Angiography
  • Glucocorticoids
  • Humans
  • Indocyanine Green
  • Male
  • Tomography, Optical Coherence
  • Visual Acuity
  • Vitelliform Macular Dystrophy
  • Vitreous Body


Entra nei temi di ricerca di 'Intravitreal dexamethasone implant for acute exudative polymorphous vitelliform maculopathy'. Insieme formano una fingerprint unica.

Cita questo